These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9385506)

  • 1. Rationale for the use of calcium antagonists in the treatment of silent myocardial ischemia.
    Cohn PF
    Clin Ther; 1997; 19 Suppl A():74-91. PubMed ID: 9385506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
    Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.
    Frishman WH; Bittar N; Glasser S; Habib G; Smith W; Pordy R
    Clin Cardiol; 1998 Jul; 21(7):483-90. PubMed ID: 9669057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
    Kobrin I; Bieska G; Charlon V; Lindberg E; Pordy R
    Cardiology; 1998; 89 Suppl 1():23-32. PubMed ID: 9570426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-blockers or calcium antagonists in silent ischaemia?
    Pepine CJ
    Eur Heart J; 1993 Oct; 14 Suppl F():7-14. PubMed ID: 7903246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of silent myocardial ischemia.
    Singh N; Langer A
    Can J Cardiol; 1995 Apr; 11(4):286-9. PubMed ID: 7728640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
    Freedman SB; Daxini BV; Noyce D; Kelly DT
    J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists for Prinzmetal's variant angina, unstable angina and silent myocardial ischemia: therapeutic tool and probe for identification of pathophysiologic mechanisms.
    Stone PH
    Am J Cardiol; 1987 Jan; 59(3):101B-115B. PubMed ID: 3544788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of silent myocardial ischemia in patients with angina and other forms of coronary heart disease.
    Pepine CJ
    Am J Med; 1986 Apr; 80(4C):25-34. PubMed ID: 2871755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of nitrates, calcium channel blockers, and beta blockers for optimal antianginal therapy.
    Cohn PF
    Clin Cardiol; 1994 Aug; 17(8):415-21. PubMed ID: 7955587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drugs acting on the heart in therapy of silent myocardial ischemia].
    Motz W; Scheler S; Strauer BE
    Internist (Berl); 1992 Oct; 33(10):695-700. PubMed ID: 1358855
    [No Abstract]   [Full Text] [Related]  

  • 12. Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris.
    Massie BM
    Am J Hypertens; 1998 Apr; 11(4 Pt 3):95S-102S. PubMed ID: 9607373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina.
    Heidenreich PA; McDonald KM; Hastie T; Fadel B; Hagan V; Lee BK; Hlatky MA
    JAMA; 1999 May; 281(20):1927-36. PubMed ID: 10349897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nipradilol on silent myocardial ischemia and heart rate variability in chronic stable angina.
    Takase B; Hikita H; Satomura K; Mastui T; Ohsuzu F; Kurita A
    Cardiovasc Drugs Ther; 2002 Jan; 16(1):43-51. PubMed ID: 12085977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts of silent myocardial ischemia.
    Bleske BE; Shea MJ
    Clin Pharm; 1990 May; 9(5):339-57. PubMed ID: 1972045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy.
    Deedwania PC; Carbajal EV
    Am J Cardiol; 1990 May; 65(16):1090-6. PubMed ID: 1970449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of anti-angina drugs].
    Silber S
    Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging options in the management of myocardial ischemia.
    Mehta JL
    Am J Cardiol; 1994 Jan; 73(3):18A-27A. PubMed ID: 7906091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.